{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "CD8+ T-cell",
      "CTL",
      "CTL epitope",
      "HIV-1",
      "HKU1",
      "OC43",
      "SARS-CoV-2 (2019-nCoV)"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33995351",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "05",
    "Day": "25"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "04",
        "Day": "28"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "627568",
      "10.3389/fimmu.2021.627568"
    ],
    "Journal": {
      "ISSN": "1664-3224",
      "JournalIssue": {
        "Volume": "12",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Frontiers in immunology",
      "ISOAbbreviation": "Front Immunol"
    },
    "ArticleTitle": "SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.",
    "Pagination": {
      "StartPage": "627568",
      "MedlinePgn": "627568"
    },
    "Abstract": {
      "AbstractText": [
        "The beta-coronavirus SARS-CoV-2 induces severe disease (COVID-19) mainly in elderly persons with risk factors, whereas the majority of patients experience a mild course of infection. As the circulating common cold coronaviruses OC43 and HKU1 share some homologous sequences with SARS-CoV-2, beta-coronavirus cross-reactive T-cell responses could influence the susceptibility to SARS-CoV-2 infection and the course of COVID-19. To investigate the role of beta-coronavirus cross-reactive T-cells, we analyzed the T-cell response against a 15 amino acid long peptide (SCoV-DP15: DLSPRWYFYYLGTGP) from the SARS-CoV-2 nucleoprotein sequence with a high homology to the corresponding sequence (QLLPRWYFYYLGTGP) in OC43 and HKU1. SCoV-DP15-specific T-cells were detected in 4 out of 23 (17.4%) SARS-CoV-2-seronegative healthy donors. As HIV-1 infection is a potential risk factor for COVID-19, we also studied a cohort of HIV-1-infected patients on antiretroviral therapy. 44 out of these 116 HIV-1-infected patients (37.9%) showed a specific recognition of the SCoV-DP15 peptide or of shorter peptides within SCoV-DP15 by CD4<sup>+</sup> T-cells and/or by CD8<sup>+</sup> T-cells. We could define several new cross-reactive HLA-I-restricted epitopes in the SARS-CoV-2 nucleoprotein such as SPRWYFYYL (HLA-B*07, HLA-B*35), DLSPRWYFYY (HLA-A*02), LSPRWYFYY (HLA-A*29), WYFYYLGTGP and WYFYYLGT. Epitope specific CD8<sup>+</sup> T-cell lines recognized corresponding epitopes within OC43 and HKU1 to a similar degree or even at lower peptide concentrations suggesting that they were induced by infection with OC43 or HKU1. Our results confirm that SARS-CoV-2-seronegative subjects can target SARS-CoV-2 not only by beta-coronavirus cross-reactive CD4<sup>+</sup> T-cells but also by cross-reactive CD8<sup>+</sup> cytotoxic T-cells (CTL). The delineation of cross-reactive T-cell epitopes contributes to an efficient epitope-specific immunomonitoring of SARS-CoV-2-specific T-cells. Further prospective studies are needed to prove a protective role of cross-reactive T-cells and their restricting HLA alleles for control of SARS-CoV-2 infection. The frequent observation of SARS-CoV-2-reactive T-cells in HIV-1-infected subjects could be a reason that treated HIV-1 infection does not seem to be a strong risk factor for the development of severe COVID-19."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Schmidt, Nganou-Makamdop, Tenbusch, El Kenz, Maier, Lapuente, \u00dcberla, Spriewald, Bergmann, Harrer and Harrer."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Infectious Disease and Immunodeficiency Section, Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Schmidt",
        "ForeName": "Katja G",
        "Initials": "KG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Nganou-Makamdop",
        "ForeName": "Krystelle",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Tenbusch",
        "ForeName": "Matthias",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Infectious Disease and Immunodeficiency Section, Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          },
          {
            "Identifier": [],
            "Affiliation": "Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "El Kenz",
        "ForeName": "Boutaina",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Maier",
        "ForeName": "Clara",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Lapuente",
        "ForeName": "Dennis",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Clinical and Molecular Virology, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "\u00dcberla",
        "ForeName": "Klaus",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine 5, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Spriewald",
        "ForeName": "Bernd",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Infectious Disease and Immunodeficiency Section, Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Bergmann",
        "ForeName": "Silke",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Infectious Disease and Immunodeficiency Section, Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Harrer",
        "ForeName": "Ellen G",
        "Initials": "EG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Infectious Disease and Immunodeficiency Section, Department of Internal Medicine 3, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, Erlangen, Germany."
          }
        ],
        "LastName": "Harrer",
        "ForeName": "Thomas",
        "Initials": "T"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Front Immunol",
    "NlmUniqueID": "101560960",
    "ISSNLinking": "1664-3224"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Epitopes, T-Lymphocyte"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nucleoproteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology"
      ],
      "DescriptorName": "CD4-Positive T-Lymphocytes"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology",
        "pathology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology",
        "pathology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cross Reactions"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology"
      ],
      "DescriptorName": "Epitopes, T-Lymphocyte"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology"
      ],
      "DescriptorName": "Nucleoproteins"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "immunology",
        "pathology"
      ],
      "DescriptorName": "T-Lymphocytes, Cytotoxic"
    }
  ],
  "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
}